Metadata Search
Aeras Global Tuberculosis Vaccine Foundation
Page 1 of 15 results
Sort by: relevance publication year Download as CSV

Tuberculosis and Healthcare Workers in Underresourced Settings

Journal Article published 26 Apr 2016 in Clinical Infectious Diseases volume 62 issue suppl 3 on pages S229 to S230

Research funded by Aeras Global Tuberculosis Vaccine Foundation | National Institutes of Health | Bill and Melinda Gates Foundation

Authors: Thomas G. Evans, Linda-Gail Bekker

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial

Journal Article published Jul 2015 in Vaccine volume 33 issue 30 on pages 3592 to 3599

Research funded by Aeras Global Tuberculosis Vaccine Foundation

Authors: Hennie Geldenhuys, Helen Mearns, David J.C. Miles, Michele Tameris, David Hokey, Zhongkai Shi, Sean Bennett, Peter Andersen, Ingrid Kromann, Søren T. Hoff, Willem A. Hanekom, Hassan Mahomed, Mark Hatherill, Thomas J. Scriba, Michele van Rooyen, J. Bruce McClain, Robert Ryall, Guy de Bruyn

Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention

Journal Article published Mar 2018 in Tuberculosis volume 109 on pages 61 to 68

Research funded by Bill and Melinda Gates Foundation (OPP1021972, OPP1023483, OPP1116632, OPP1137034) | Center for Global Health | National Institutes of Health (RO1-AI087915) | South African Medical Research Council (TB/HIV/AIDS-01-2014) | Strategic Health Innovation Partnerships | Department of Science and Technology, Republic of South Africa | Aeras Global Tuberculosis Vaccine Foundation | BMGF GC 6-74 (37772) | BMGF GC 12 (37885)

Authors: Andrew Fiore-Gartland, Lindsay N. Carpp, Kogieleum Naidoo, Ethan Thompson, Daniel E. Zak, Steve Self, Gavin Churchyard, Gerhard Walzl, Adam Penn-Nicholson, Thomas J. Scriba, Mark Hatherill

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

Journal Article published Mar 2015 in The Lancet Respiratory Medicine volume 3 issue 3 on pages 190 to 200

Research funded by European and Developing Countries Clinical Trials Partnership (IP.07.32080.002) | Aeras Global Tuberculosis Vaccine Foundation | Bill and Melinda Gates Foundation | Wellcome Trust (095780, 084323, 088316) | Oxford-Emergent Tuberculosis Consortium

Authors: Birahim Pierre Ndiaye, Friedrich Thienemann, Martin Ota, Bernard S Landry, Makhtar Camara, Siry Dièye, Tandakha Ndiaye Dieye, Hanif Esmail, Rene Goliath, Kris Huygen, Vanessa January, Ibrahima Ndiaye, Tolu Oni, Michael Raine, Marta Romano, Iman Satti, Sharon Sutton, Aminata Thiam, Katalin A Wilkinson, Souleymane Mboup, Robert J Wilkinson, Helen McShane

Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis

Journal Article published 9 May 2017 in mBio volume 8 issue 3 on page e00312-17

Research funded by Harvard Center for AIDS Research (A1060354) | National Institutes of Health (AI114674, AI089443) | Burroughs Wellcome Fund | Aeras Global Tuberculosis Vaccine Foundation

Authors: Constance J. Martin, Anthony M. Cadena, Vivian W. Leung, Philana Ling Lin, Pauline Maiello, Nathan Hicks, Michael R. Chase, JoAnne L. Flynn, Sarah M. Fortune

Editors: Christina L. Stallings

Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine

Journal Article published 9 Mar 2017 in PLOS Pathogens volume 13 issue 3 on page e1006250

Research funded by National Institute of Allergy and Infectious Diseases (AI105684, AI096213-01, 1R21AI115091) | Aeras Global Tuberculosis Vaccine Foundation (1U18 FD004012) | Juergen Manchot Foundation | Alberta Glycomics Centre | Secretaría de Estado de Investigación, Desarrollo e Innovación (Ramon y Cajal Award) | Ikerbasque, Basque Foundation for Science

Authors: Rafael Prados-Rosales, Leandro Carreño, Tingting Cheng, Caroline Blanc, Brian Weinrick, Adel Malek, Todd L. Lowary, Andres Baena, Maju Joe, Yu Bai, Rainer Kalscheuer, Ana Batista-Gonzalez, Noemi A. Saavedra, Leticia Sampedro, Julen Tomás, Juan Anguita, Shang-Cheng Hung, Ashish Tripathi, Jiayong Xu, Aharona Glatman-Freedman, Williams R. Jacobs, John Chan, Steven A. Porcelli, Jacqueline M. Achkar, Arturo Casadevall

Editors: Padmini Salgame

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Journal Article published Aug 2015 in Vaccine volume 33 issue 33 on pages 4130 to 4140

Research funded by Aeras Global Tuberculosis Vaccine Foundation

Authors: Angelique Kany Kany Luabeya, Benjamin M.N. Kagina, Michele D. Tameris, Hennie Geldenhuys, Soren T. Hoff, Zhongkai Shi, Ingrid Kromann, Mark Hatherill, Hassan Mahomed, Willem A. Hanekom, Peter Andersen, Thomas J. Scriba, Elisma Schoeman, Colleen Krohn, Cheryl L. Day, Hadn Africa, Lebohang Makhethe, Erica Smit, Yolande Brown, Sara Suliman, E. Jane Hughes, Peter Bang, Margaret A. Snowden, Bruce McClain, Gregory D. Hussey

Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901

Journal Article published 12 May 2017 in PLOS ONE volume 12 issue 5 on page e0175215

Research funded by Dartmouth College | Aeras Global Tuberculosis Vaccine Foundation | Jack and Dorothy Byrne Foundation

Authors: C. Fordham von Reyn, Timothy Lahey, Robert D. Arbeit, Bernard Landry, Leway Kailani, Lisa V. Adams, Brenda C. Haynes, Todd Mackenzie, Wendy Wieland-Alter, Ruth I. Connor, Sue Tvaroha, David A. Hokey, Ann M. Ginsberg, Richard Waddell

Editors: Ray Borrow

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy

Journal Article published Sep 2016 in Vaccine volume 34 issue 39 on pages 4656 to 4665

Research funded by Universities Federation for Animal Welfare | EURIPRED | Aeras Global Tuberculosis Vaccine Foundation

Authors: Rachel Tanner, Matthew K. O’Shea, Helen A. Fletcher, Helen McShane

Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E

Journal Article published 21 Jan 2016 in Science volume 351 issue 6274 on pages 714 to 720

Research funded by National Institutes of Health (P01-AI094417, R37-AI054292, R01-DE021291, R01-AI095113, R01-AI117802, R01-AI059457, U24-OD010850, P51-OD011092, P50-GM065794, HHSN272201100013C) | Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1-AI100645-01) | Bill and Melinda Gates Foundation (OPP1108533, OPP1133649) | Aeras Global Tuberculosis Vaccine Foundation | Los Alamos National Laboratory

Authors: S. G. Hansen, H. L. Wu, B. J. Burwitz, C. M. Hughes, K. B. Hammond, A. B. Ventura, J. S. Reed, R. M. Gilbride, E. Ainslie, D. W. Morrow, J. C. Ford, A. N. Selseth, R. Pathak, D. Malouli, A. W. Legasse, M. K. Axthelm, J. A. Nelson, G. M. Gillespie, L. C. Walters, S. Brackenridge, H. R. Sharpe, C. A. Lopez, K. Fruh, B. T. Korber, A. J. McMichael, S. Gnanakaran, J. B. Sacha, L. J. Picker